Molecular Characterization of Chronic Obstructive Pulmonary Disease-Related Non-Small Cell Lung Cancer Through Aberrant Methylation and Alterations of EGFR Signaling

作者：Suzuki Makoto^*; Wada Hironobu; Yoshino Mitsuru; Tian Lei; Shigematsu Hisayuki; Suzuki Hidemi; Alaa Mahmoud; Tamura Hajime; Fujiwara Taiki; Nagato Kaoru; Motohashi Shinichiro; Moriya Yasumitsu; Hoshino Hidehisa; Yoshida Shigetoshi; Shibuya Kiyoshi; Hiroshima Kenzo; Nakatani Yukio; Yoshino Ichiro

来源：Annals of Surgical Oncology, 2010, 17(3): 878-888.

DOI：10.1245/s10434-009-0739-3

The aim of this study was to evaluate the molecular influence of chronic obstructive pulmonary diseases (COPD) on the pathogenesis of non-small cell lung cancer (NSCLC).
The methylation profiles of 12 genes, and the epidermal growth factor receptor (EGFR) and KRAS mutations were determined for samples from 229 NSCLC patients. In addition, protein expression of EGFR and HER2 in 116 NSCLCs was analyzed based on the presence or absence of COPD.
IL-12R beta 2 and Wif-1 methylation and HER2 overexpression were more frequent events in the COPD group. Eighty nonmalignant lung tissues had no correlation with any molecular changes between the COPD and the non-COPD group. EGFR mutation was significantly higher in the non-COPD group, while EGFR expression was inversely correlated with %FEV1.0. In the COPD group, unmethylated SPARC and sFRP-2 genes or a negative CpG island methylator phenotype (CIMP) was a negative prognostic factor, while methylation of p16(INK4A) and WNT antagonist genes was a negative prognostic factor in the non-COPD group.
Novel characteristics of COPD-related NSCLC were identified by examination of methylation profiles and alterations of EGFR signaling. In consideration of the high sensitivity to smoking in patients with COPD, NSCLC with COPD might be a distinct population of smoke-related NSCLC, the genetic profile of which is quite different from non-COPD NSCLC.

• 出版日期2010-3